AffRegion.i
Exploration
Accueil
Racine
Exploration
Accueil

Gentilly AND (oncology OR urology) - Exploration (Accueil)

Index « AffRegion.i » - entrée « Provence-Alpes-Côte d'Azur »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Poitou-Charentes < Provence-Alpes-Côte d'Azur < Rhône-Alpes  Facettes :

List of bibliographic references indexed by Provence-Alpes-Côte d'Azur

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]**** probable Xml problem ****
Ident.Authors (with country if any)Title
000000 (2024) Ang Xe9 Line Galvin [France] ; Nicolas Bertrand ; Rabia Boulahssass ; Laure De Decker ; Etienne Dorval [France] ; B Xe9 Atrice Clairaz [France] ; Monique Castaign Xe8 De [France] ; Loic Mourey ; Capucine Baldini [France] ; Eric Bauvin [France] ; B Xe9 Atrice Jacques [France] ; Isabelle Mallon [France] ; Isabelle Durand-Zaleski [France] ; Olivier Gu Xe9 Rin [France] ; Sadek Krouri [France] ; Pierre SoubeyranRethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group.
000004 (2023) Karen Leroy [France] ; Clarisse Audigier Valette [France] ; J Xe9 R Xf4 Me Alexandre [France] ; Lise Boussemart [France] ; Jean Chiesa [France] ; Clotilde Deldycke [France] ; Carlos Gomez-Rocca [France] ; Antoine Hollebecque [France] ; Jacqueline Lehmann-Che [France] ; Antoinette Lemoine [France] ; Sandrine Mansard [France] ; Jacques Medioni [France] ; Isabelle Monnet [France] ; Samia Mourah [France] ; Thomas Pierret [France] ; Dominique Spa Xeb Th [France] ; Alexandre Civet [France] ; Sandrine Galoin [France] ; Antoine Italiano [France]Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
000005 (2023) Helo Xef Se Bourien [France] ; Le Xef La Bengrine Lefevre [France] ; Marie-Ange Mouret-Reynier [France] ; Bernard Asselain [France] ; Brigitte Lucas [France] ; Celine Gavoille [France] ; Corina Cornila [France] ; Laurene Gavoille [France] ; Emeline Colomba [France] ; Anne Patsouris [France] ; Michel Fabbro [France] ; Camille Chakiba [France] ; Philippe Toussaint [France] ; Helene Simon [France] ; Dominique Berton [France] ; Delphine Garbay [France] ; Claire Garnier Tixidre [France] ; David Coeffic [France] ; Aurelie Morvan [France] ; Olivier Collard [France] ; Thibault De La Motte Rouge [France]Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
000006 (2023) Xavier Pivot [France] ; Jean-Philippe Spano [France] ; Marc Espie [France] ; Christelle Jouannaud [France] ; Valerie Pottier [France] ; Laura Moreau [France] ; Jean Marc Extra [France] ; Alain Lortholary [France] ; Pascale Rivera [France] ; Dominique Spaeth [France] ; Zahira Mouri [France] ; Fella Tariket [France] ; Julien Dupin [France] ; Aurelien Berthois [France] ; Miruna Ionescu-Goga [France] ; Abdennour Ferhat [France] ; Paul Cottu [France] ; Joseph Gligorov [France]Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
000008 (2023) Caroline Bailleux [France] ; Antoine Arnaud [France] ; Jean-S Xe9 Bastien Frenel [France] ; Sylvie Chabaud [France] ; Thomas Bachelot [France] ; Beno Xee T You [France] ; La Xeb Titia Stefani [France] ; Claire Garnier Tixidre [France] ; H Xe9 L Xe8 Ne Simon [France] ; Dominique Beal-Ardisson [France] ; Jean-Philippe Jacquin [France] ; Francesco Del Piano [France] ; Alain Lortholary [France] ; Claudiu Cornea [France] ; Charlotte Greilsamer [France] ; R Xe9 My Largillier [France] ; Fabien Brocard [France] ; Eric Legouffe [France] ; Mustapha Atlassi [France] ; Anne-Claire Hardy-Bessard [France] ; Pierre-Etienne Heudel [France]CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
000009 (2022) Ang Xe9 Line Galvin [France] ; Nicolas Bertrand [France] ; Rabia Boulahssass [France] ; Laure De Decker [France] ; Xc9 Tienne Dorval [France] ; B Xe9 Atrice Clairaz [France] ; Monique Castaign Xe8 De [France] ; Lo Xef C Mourey [France] ; Capucine Baldini [France] ; Eric Bauvin [France] ; B Xe9 Atrice Jacques [France] ; Isabelle Mallon [France] ; Isabelle Durand-Zaleski [France] ; Olivier Gu Xe9 Rin [France] ; Sadek Krouri [France] ; Pierre Soubeyran [France][Rethinking the management of elderly cancer patients : Proposals from the Age Cancer Priorities French Group].
000014 (2022) Olivier Tr Xe9 Dan [France] ; Magali Provansal [France] ; Cyril Abdeddaim [France] ; Audrey Lardy-Cleaud [France] ; Anne-Claire Hardy-Bessard [France] ; Elsa Kalbacher [France] ; Anne Floquet [France] ; Laurence Venat-Bouvet [France] ; Alain Lortholary [France] ; Oana Pop [France] ; Jean-S Xe9 Bastien Frenel [France] ; Mathilde Cancel [France] ; R Xe9 My Largillier [France] ; Christophe Louvet [France] ; Beno Xee T You [France] ; Alain Zannetti [France] ; Amelie Anota [France] ; Isabelle Treilleux [France] ; Daniel Pissaloux [France] ; Aur Xe9 Lie Houlier [France] ; Aude-Marie Savoye [France] ; Marie-Ange Mouret-Reynier [France] ; J Xe9 R Xf4 Me Meunier [France] ; Charles-Briac Levach Xe9 [France] ; Fabien Brocard [France] ; Isabelle Ray-Coquard [France]Regorafenib or Tamoxifen for platinum-sensitive recurrent ovarian cancer with rising CA125 and no evidence of clinical or RECIST progression: A GINECO randomized phase II trial (REGOVAR).
000015 (2022) Florence Joly [France] ; Michel Fabbro [France] ; Dominique Berton [France] ; Justine Lequesne [France] ; Am Xe9 Lie Anota [France] ; Alicja Puszkiel [France] ; Anne Floquet [France] ; H Xe9 L Xe8 Ne Vegas [France] ; Hugues Bourgeois [France] ; Le Xef La Bengrine Lefevre [France] ; Beno Xee T You [France] ; Fanny Pommeret [France] ; Alain Lortholary [France] ; Dominique Spaeth [France] ; Anne-Claire Hardy-Bessard [France] ; Cyril Abdeddaim [France] ; Marie-Christine Kaminsky-Forrett [France] ; Michel Tod [France] ; Jean-Emmanuel Kurtz [France] ; Francesco Del Piano [France] ; J Xe9 R Xf4 Me Meunier [France] ; Nadia Raban [France] ; J Xe9 Rome Alexandre [France] ; Marie-Ange Mouret-Reynier [France] ; Isabelle Ray-Coquard [France] ; Magali Provansal Gross [France] ; Pierre-Emmanuel Brachet [France]Paclitaxel with or without pazopanib for ovarian cancer relapsing during bevacizumab maintenance therapy: The GINECO randomized phase II TAPAZ study.
000024 (2021) Candice Hober [France] ; Lisa Fredeau [France] ; Anne Pham-Ledard [France] ; Marouane Boubaya [France] ; Florian Herms [France] ; Philippe Celerier [France] ; Fran Xe7 Ois Aubin [France] ; Nathalie Beneton [France] ; Monica Dinulescu [France] ; Arnaud Jannic [France] ; Nicolas Meyer [France] ; Anne-B Xe9 N Xe9 Dicte Duval-Modeste [France] ; Laure Cesaire [France] ; Xc8 Ve-Marie Neidhardt [France] ; Xc9 Lodie Archier [France] ; Brigitte Dr Xe9 No [France] ; Candice Lesage [France] ; Cl Xe9 Mence Berthin [France] ; Nora Kramkimel [France] ; Florent Grange [France] ; Julie De Quatrebarbes [France] ; Pierre-Emmanuel Stoebner [France] ; Nicolas Poulalhon [France] ; Jean-Philippe Arnault [France] ; Safia Abed [France] ; Bertille Bonniaud [France] ; Sophie Darras [France] ; Valentine Heidelberger [France] ; Suzanne Devaux [France] ; Marie Moncourier [France] ; Laurent Misery [France] ; Sandrine Mansard [France] ; Maxime Etienne [France] ; Florence Brunet-Possenti [France] ; Caroline Jacobzone [France] ; Romain Lesbazeilles [France] ; Fran Xe7 Ois Skowron [France] ; Julia Sanchez [France] ; St Xe9 Phanie Catala [France] ; Mahtab Samimi [France] ; Youssef Tazi [France] ; Dominique Spaeth [France] ; Caroline Gaudy-Marqueste [France] ; Olivier Collard [France] ; Raoul Triller [France] ; Marc Pracht [France] ; Marc Dumas [France] ; Lucie Peuvrel [France] ; Pierre Combe [France] ; Olivier Lauche [France] ; Pierre Guillet [France] ; Yves Reguerre [France] ; Ingrid Kupfer-Bessaguet [France] ; David Solub [France] ; Am Xe9 Lie Schoeffler [France] ; Christophe Bedane [France] ; Ga Xeb Lle Qu Xe9 Reux [France] ; Sophie Dalac [France] ; Laurent Mortier [France] ; Xc8 Ve Maubec [France]Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
000027 (2020) Fr Xc9 D Xc9 Ric Selle [Soudan du Sud] ; Pierre-Etienne Heudel [France] ; Anne-Claire Hardy-Bessard [France] ; Astrid Pozet [France] ; Jerome Meunier [France] ; Laurence Gladieff [France] ; Jean-Pierre Lotz [France] ; Magali Provansal [France] ; Paule Augereau [France] ; Dominique Berton [France] ; Nathalie Bonichon-Lamichhane [France] ; Hubert Orfeuvre [France] ; Patricia Pautier [France] ; Elsa Kalbacher [France] ; Yousef Tazi [France] ; Dominique Spaeth [France]GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer.
000028 (2020) Anne-Claire Hardy-Bessard [France] ; Fabien Brocard [France] ; Florian Clatot [France] ; Alain Lortholary [France] ; Beno Xee T You [France] ; Julien Grenier [France] ; J Xe9 R Xf4 Me Martin-Babau [France] ; Brigitte Lucas [France] ; J Xe9 R Xf4 Me Meunier [France] ; Jean-Marc Ferrero [France] ; Aude-Marie Savoye [France] ; Adina Marti [France] ; Raymond Despax [France] ; Isabelle Moullet [France] ; George Emile [France]First-line bevacizumab and eribulin combination therapy for HER2-negative metastatic breast cancer: Efficacy and safety in the GINECO phase II ESMERALDA study.
000029 (2020) Nicolas Delanoy [France] ; Anne-Claire Hardy-Bessard [France] ; Eleni Efstathiou [États-Unis] ; Sylvestre Le Moulec [France] ; Umberto Basso [Italie] ; Alison Birtle [Royaume-Uni] ; Alastair Thomson [Royaume-Uni] ; Michael Krainer [Autriche] ; Aline Guillot [France] ; Ugo De Giorgi [Italie] ; Ali Hasbini [France] ; Gedske Daugaard [Danemark] ; Amit Bahl [Royaume-Uni] ; Simon Chowdhury [Royaume-Uni] ; Orazio Caffo [Italie] ; Philippe Beuzeboc [France] ; Dominique Spaeth [France] ; Jean-Christophe Eymard [France] ; Aude Fl Xe9 Chon [France] ; Jerome Alexandre [France] ; Carole Helissey [France] ; Mohamed Butt [Royaume-Uni] ; Frank Priou [France] ; Eric Lechevallier [France] ; Jean-Laurent Deville [France] ; Marine Gross-Goupil [France] ; Rafael Morales [Espagne] ; Antoine Thiery-Vuillemin [France] ; Tatiana Gavrikova [France] ; Philippe Barth Xe9 L Xe9 My [France] ; Avishay Sella [Israël] ; Karim Fizazi [France] ; Jean-Marc Ferrero [France] ; Brigitte Laguerre [France] ; Constance Thibault [France] ; Sophie Hans [France] ; St Xe9 Phane Oudard [France]Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163].
000030